Prevalence, risk factors and genotypes of hepatitis C virus infection among drug users, Central-Western Brazil;Prevalencia, factores de riesgo y genotipos de la hepatitis C entre usuarios de drogas

Revista de Saude Publica

Volumn 43, Issue SUPPL. 1, 2009, Pages 43-50

  Lopes, Carmen L R ^a   Teles, Sheila A ^a   Espírito Santo, Márcia P ^b   Lampe, Elisabete ^b   Rodrigues, Fabiana P ^c   Motta Castro, Ana Rita C ^d   Marinho, Thaís A ^a   Reis, Nádia R ^a   Silva, Ágabo M C ^a   Martins, Regina M B ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c UNIVERSIDADE ESTADUAL DE MATO GROSSO DO SUL   (Brazil)

^d FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

Author keywords

Hepacivirus, genetics; Hepatitis C antibodies, diagnostic use; Hepatitis C.; Needle sharing; Risk factors; Seroepidemiologic studies; Substance abuse, Intravenous

Indexed keywords

DIAGNOSTIC AGENT; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; BRAZIL; CROSS-SECTIONAL STUDY; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTOR; SOCIOECONOMICS; STATISTICS; SUBSTANCE ABUSE; VIROLOGY;

ADULT; BRAZIL; CROSS-SECTIONAL STUDIES; DRUG USERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOBLOTTING; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTORS; RNA, VIRAL; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 77449129364     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0034-89102009000800008     Document Type: Article

References (25)

1. Alter MJ. Epidemiology of viral hepatitis C infection. World J Gastroenterol. 2007;13(17):2436-41.
2. Bastos FI, Lowndes CM, Castelo-Branco LR, Linhares-de-Carvalho MI, Oeleman W, Bernier F, et al. Sexual behaviour and infection rates for HIV, blood-borne and sexually transmitted infections among patients attending drug treatment centres in Rio de Janeiro, Brazil. Int J STD AIDS. 2000;11(6):383-92. DOI: 10.1258/0956462001916100
3. Blackard JT, Shata MT, Shire NJ, Sherman KE. Acute hepatitis C virus infection: a chronic problem. Hepatology. 2008;47(1):321-31. DOI: 10.1002/hep.21902
4. Botelho SM, Ferreira RC, Reis NR, Kozlowski AG, Carneiro MA, Teles SA, et al. Epidemiological aspects of hepatitis C virus infection among renal transplant recipients in Central Brazil. Mem Inst Oswaldo Cruz. 2008;103(5):472-6. DOI: 10.1590/S0074-02762008000500011
5. Campiotto S, Pinho JRR, Carrilho FJ, Da Silva LC, Souto FJD, Spinelli V, et al. Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res. 2005;38(1):41-9. DOI: 10.1590/S0100-879X2005000100007
6. Carneiro MA, Teles SA, Lampe E, Espírito-Santo MP, Gouveia-Oliveira R, Reis NR, et al. Molecular and epidemiological study on nosocomial transmission of HCV in hemodialysis patients in Brazil. J Med Virol. 2007;79(9):1325-33. DOI: 10.1002/jmv.20932
7. Carvalho HB, Seibel SD, Burattini MN, Massad E, Reingold A. Vulnerabilidade às infecções pelo HIV, hepatites B e C e sífilis entre adolescentes infratores institucionalizados na cidade de São Paulo, Brasil. J Bras Doenças Sex Transm. 2003;15(3):41-5.
8. Des Jarlais DC, Perlis TE, Stimson GV, Poznyak V; WHO Phase II Drug Injection Collaborative Study Group. Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II. BMC Public Health. 2006;6:54. DOI: 10.1186/1471-2458-6-54
9. Espírito-Santo MP, Carneiro MAS, Reis NRS, Kozlowski AG, Teles SA, Lampe E, et al. Genotyping hepatitis C virus from hemodialysis patients in Central Brazil by line probe assay and sequence analysis. Braz J Med Biol Res. 2007;40(4):545-50. DOI: 10.1590/S0100-879X2007000400013
10. Galperim B, Cheinquer H, Stein A, Fonseca A, Lunge V, Ikuta N. Intranasal cocaine use does not appear to be an independent risk factor for HCV infection. Addiction. 2004;99(8):973-7. DOI: 10.1111/j.1360-0443.2004.00761.x
11. Ginabreda MGP, Yoshida CFT, Niel C. Genomic characterization of Brazilian hepatitis C virus genotypes 1a and 1b. Braz J Med Biol Res. 1997;30(3):339-45. DOI: 10.1590/S0100-879X1997000300006
12. Howe CJ, Fuller CM, Ompad DC, Galea S, Klobin B, Thomas D, et al. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. Drug Alcohol Depend. 2005;79(3):389-95. DOI: 10.1016/j.drugalcdep.2005.03.004
13. Jittiwutikarn J, Thongsawat S, Suriyanon V, Maneekarn N, Celentano D, Razak MH, et al. Hepatitis C infection among drug users in northern Thailand. Am J Trop Med Hyg. 2006;74(6):1111-6.
14. Kumar S, Tamura K, Jakobsen IB, Nei M. MEGA2: molecular evolutionarygenetics analysis software. Bioinformatics. 2001;17(12):1244-5. DOI: 10.1093/bioinformatics/17.12.1244
15. Laperche S, Lunel F, Izopet J, Alain S, Dény P, Duverlie G, et al. Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study. J Clin Microbiol. 2005;43(2):733-9. DOI: 10.1128/JCM.43.2.733-739.2005
16. Macías J, Palacios RB, Claro E, Vargas J, Vergara S, Mira JA, et al. High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack. Liver Int. 2008;26:781-6.
17. Martins RBM, Vanderborght BOM, Rouzere CD, Santana CL, Santos CO, Mori DN, et al. Anti-HCV related to HCV PCR and risk factors analysis in a blood donor population of Central Brazil. Rev Inst Med Trop São Paulo. 1994;36(6):501-6. DOI: 10.1590/S0036-46651994000600005
18. Martins RBM, Teles SA, Freitas NR, Motta-Castro ARC, Souto FJD, Mussi A, et al. Distribution of hepatitis C virus genotypes among blood donors from mid-west region of Brazil. Rev Inst Med Trop São Paulo. 2006;48(1):53-5. DOI: 10.1590/S0036-46652006000100012
19. Monteiro MR, do Nascimento MM, Passos AD, Figueiredo JF. Hepatite C: prevalência e fatores de risco entre portadores do VIH/SIDA em Belém, Pará, na Amazônia brasileira. Rev Soc Bras Med Trop. 2004;37(Supl 2):40-6.
20. Oliveira MLA, Bastos FI, Telles PR, Hacker MA, Oliveira SAN, Miguel JC, Yoshida CFT. Epidemiological and genetic analyses of hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil. J Clin Virol. 2009;44(3):200-6. DOI: 10.1016/j.jcv.2008.12.008
21. Quaglio G, Lugoboni F, Pajusco B, Sarti M, Talamini G, Lechi A, et al. Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy. Clin Infect Dis. 2003;37(1):33-40. DOI: 10.1086/375566
22. Sandres-Sauné K, Deny P, Pasquier C, Thibaut V, Duverlie G, Izopet J. Determining hepatitis C genotype by analyzing the sequence of the NS5B region. J Virol Methods. 2003;109(2):187-93. DOI: 10.1016/S0166-0934(03)00070-3
23. Segurado AC, Braga P, Etzel A, Cardoso MRA. Hepatitis C virus coinfection in a cohort of HIV-infected individuals from Santos, Brazil: Seroprevalence and associated factors. AIDS Patient Care STDS. 2004;18(3):135-43. DOI: 10.1089/108729104322994829
24. Simmonds P, Bukh J, Combet C, Deléage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 2005;42(4):962-73. DOI: 10.1002/hep.20819
25. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997;25(24):4876-82. DOI: 10.1093/nar/25.24.4876